Press release
Hautuki, Safe and Easy Supplements: Gentle on Skin, Hassle-Free Patch
Custics announced the release of "Hautuki," a height growth supplement using patented peptide technology developed by the Department of Biotechnology at Seoul National University.
A Custics official stated that the peptide technology promotes the intracellular delivery of nutrients, enhancing absorption without the need for oral administration. "Hautuki" is registered with the U.S. FDA OTC and has passed skin irritation tests with zero score.
The supplement is rich in nutrients like vitamin D3, vitamin K1, and magnesium, which aid in calcium synthesis, prevent calcium loss, and improve metabolic function. It's easy to use; simply apply it to thin skin areas such as the back of the hand, knee, or top of the foot before bedtime.
Custics is offering promotional discounts, including a 10% discount for new members and those who post reviews on the Hautuki website.
They also provide savings for bundle purchases, with options for 1, 5, or 10 packs.
Official Website: https://hautuki.sg [https://hautuki.sg/]
Media Contact
Company Name: Hautuki
Contact Person: Erick Park
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hautuki-safe-and-easy-supplements-gentle-on-skin-hasslefree-patch]
Address:8 MARINA VIEW #39-04 ASIA SQUARE TOWER 1
City: SINGAPORE (018960)
Country: Singapore
Website: https://hautuki.sg/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hautuki, Safe and Easy Supplements: Gentle on Skin, Hassle-Free Patch here
News-ID: 3618074 • Views: …
More Releases from ABNewswire
CloudMile Named Strategic Partner to Drive Enterprise AI Adoption Under Singapor …
Image: https://www.abnewswire.com/upload/2025/11/e9a6696a63928d207152b4c13b42d7d5.jpg
SINGAPORE - November 18th, 2025 - CloudMile, a leading AI company in Asia, has been appointed by Digital Industry Singapore (DISG) as one of the technology partners under the Enterprise Compute Initiative (ECI). This partnership marks a significant step in Singapore's national push to strengthen AI adoption and innovation across its enterprise landscape, as outlined in Budget 2025.
CloudMile Named Key Partner in Singapore's National AI Push Under Budget 2025
Launched…
Red Oak Hospice Brings Compassionate Care to Bridgeton: Tailored Palliative and …
Red Oak Hospice brings tailored palliative and hospice care to Bridgeton, ensuring local families receive compassionate support when they need it most.
Bridgeton, NJ - Red Oak Hospice, a trusted provider of compassionate end-of-life care, is proud to offer its expert hospice care services to families in the Bridgeton, NJ area. With a focus on personalized care, Red Oak Hospice ensures that individuals facing life-limiting illnesses and their families receive the…
MyIPNow Launches as a Next-Generation Suite of Free IP & Networking Tools for Gl …
So, there's this new thing called MyIPNow that just launched. It's basically a bunch of free tools for checking your IP address and other network stuff. It seems like they're trying to make it easier for everyone, no matter where they are, to get a handle on their internet connection and security. I've been hearing a bit about it, and it sounds like it could be pretty handy.
Key Takeaways
* MyIPNow…
Pixazo Launches Unified Visual AI API to Power the Next Generation of Multimodal …
Pixazo launches a Unified Visual AI API offering one-key access to 600+ models for image, video, audio, avatar, lip sync, and virtual try-on generation.
New Delhi, India - November 18, 2025 - Pixazo [https://www.pixazo.ai/] today announced the launch of its Unified Visual AI API, a single-key platform engineered to power the next great leap in digital creativity. As the world moves beyond text-based intelligence and into a multimodal era, Pixazo aims…
More Releases for Hautuki
Hautuki Patch Demonstrates Growth Potential and Safety in Clinical Study
Hautuki Clinically Proven to Support Height Growth and Ensure Safety
Custics announced that its height-supporting nutrient patch, Hautuki, has been proven effective and safe through a clinical study conducted at Bestian Hospital over the course of approximately one year.
Image: https://www.abnewswire.com/upload/2025/05/75daaface7cea909f35fd494150fea0f.PNG
The study was conducted over 11 months, from January to November 2024, and involved 40 children between the ages of 5 and 12.
After eight weeks, the group that used the Hautuki patch…
CUSTICS SINGAPORE's Growth Nutrient Patch 'Hautuki' Completes Clinical Study
Image: https://www.abnewswire.com/upload/2025/01/d0c11fb6ef950d96ffc92b987934691b.jpg
CUSTICS SINGAPORE PTE. LTD. (hereafter referred to as "CUSTICS SINGAPORE [https://hautuki.sg/]") has successfully completed clinical study on its 'Hautuki [https://hautuki.sg/]' growth nutrient patch in collaboration with Bestian Hospital, demonstrating its effectiveness in promoting height growth and confirming its safety. The study was conducted in adherence to Good Clinical Practice (GCP) standards and the approval of the Institutional Review Board (IRB), ensuring its reliability.
From January to November 2024, the study…
Hautuki, A Globally Recognized Innovative Patch Type Nutrition Solution for Chil …
Hautuki, an innovative children's nutrition product manufactured in South Korea, is gaining global recognition. Exported to countries including the United States, Singapore, Hong Kong, Taiwan, Malaysia, Indonesia, China, and the Philippines, Hautuki has established itself as a trusted brand in international markets.
CUSTICS, the company behind Hautuki, operates legal entities in South Korea, Singapore, Taiwan, and Hong Kong, strengthening its global presence. Based on its vision to "shine and illuminate," CUSTICS…
HAUTUKI Innovates Efficient Vitamin D Delivery for Children through Transdermal …
Recent nutritional surveys conducted both domestically and internationally indicate that more than 80% of children in their growth phase suffer from vitamin D deficiency or insufficiency. Research also shows that children with stunted growth are more prone to vitamin D deficiency compared to their peers. In countries with frequent rainy or overcast days, ensuring adequate vitamin D intake is naturally more challenging.
Image: https://www.abnewswire.com/uploads/d2d7d3db97fca5f29490d3971d5e13d5.jpg
CUSTICS Inc. (CEO LEE KANG IL), in their…
Custics Singapore's HAUTUKI Secures FDA OTC Product Registration and Excels in S …
Custics Singapore announces that HAUTUKI has achieved a significant milestone by securing registration as an OTC Product with the U.S. FDA
HAUTUKI, a cutting-edge product developed through technology transferred from Seoul National University, integrates a unique blend of vitamins and nutrients designed to amplify its effectiveness. At the core of HAUTUKI's innovation is a patented peptide ligand from the Department of Biotechnology at Seoul National University. This advanced technology is engineered…
CUSTICS Launches Hautuki as an OTC Product in Singapore
CUSTICS SINGAPORE PTE. LTD. has announced that its product, Hautuki, has already completed registration with the U.S. FDA Administration OTC Product.
According to a company representative, Hautuki was developed by CUSTICS Co., Ltd. using TDDS technology previously acquired from Seoul National University. This innovative patch integrates vitamins and various nutrients and is specifically designed to support children's growth.
Image: https://www.abnewswire.com/uploads/85ea01f2e25cff2bd5d8e29463a3d6d2.png
The technology is the "Pore-Permeable Transdermal Peptide Ligand," a patented innovation from the…
